MétaCan
Menu
Back to cohort
Record W2991173142 · doi:10.1002/prp2.519

Evaluation of pharmacokinetics and safety of cetuximab with cisplatin/carboplatin in patients with advanced solid tumor: Result from phase II studies

2019· article· en· W2991173142 on OpenAlexaff
Raymond P. Perez, Eric X. Chen, J. Thaddeus Beck, Keisuke Shirai, D. Neil Hayes, Tong Shen, John R. Baldwin, Katherine Bryant, Shuang He, Steve Chin

Bibliographic record

VenuePharmacology Research & Perspectives · 2019
Typearticle
Languageen
FieldMedicine
TopicColorectal Cancer Treatments and Studies
Canadian institutionsPrincess Margaret Cancer Centre
FundersNational Cancer InstituteEli Lilly and Company
KeywordsCetuximabCarboplatinCisplatinCmaxPharmacokineticsMedicinePharmacologyTolerabilityOncologyInternal medicineCancerAdverse effectChemotherapyColorectal cancer

Abstract

fetched live from OpenAlex

Abstract The pharmacokinetics and potential drug–drug interactions between cetuximab and cisplatin or carboplatin from two studies (JXBA and JXBB) were evaluated. These studies were multicenter, open‐label phase II trials designed to evaluate the drug–drug interactions between cetuximab (400 mg m −2 initial dose) and cisplatin (JXBA; 100 mg m −2 ) or carboplatin (JXBB; area under the curve [AUC] = 5 mg × min mL −1 ) with or without 5‐fluorouracil (5FU) in patients with advanced solid tumors. Concentrations of cetuximab, cisplatin and carboplatin were determined using analytical methods. The safety and tolerability of cetuximab in combination with cisplatin or carboplatin was also determined in all treated patients. The JXBA study showed that cetuximab serum concentrations were similar when cetuximab was administered alone or in combination with cisplatin. The C max , t max and overall AUC for the cetuximab group (194 µg mL −1 , 2.0 hour, 14 900 µg × h mL −1 ) and the cetuximab and cisplatin combination group (192 µg mL −1 , 1.99 hour, 16 300 µg × h mL −1 ) were similar. The JXBB study showed that mean cetuximab serum concentrations were similar when cetuximab was administered alone or in combination with carboplatin. The C max , t max and overall AUC for the cetuximab group (199 µg mL −1 , 1.15 hour, 17 200 µg × h mL −1 ) and the cetuximab and carboplatin combination group (199 µg mL −1 , 3.17 h, 16 800 µg × h mL −1 ) were similar. Both studies showed that the safety profile was consistent with known side effects of cetuximab, platinum–based therapies and 5‐FU. There was no clinically relevant change in cetuximab pharmacokinetics when it was administered in combination with cisplatin or carboplatin.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.202
Threshold uncertainty score0.540

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.060
GPT teacher head0.463
Teacher spread0.404 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2019
Admission routes1
Has abstractyes

Explore more

Same venuePharmacology Research & PerspectivesSame topicColorectal Cancer Treatments and StudiesFrench-language works237,207